A retrospective, pilot study to evaluate the feasibility of ferumoxytol as an off-label contrast agent in body 3T MR angiography in children

Trial Profile

A retrospective, pilot study to evaluate the feasibility of ferumoxytol as an off-label contrast agent in body 3T MR angiography in children

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Apr 2016

At a glance

  • Drugs Ferumoxytol (Primary)
  • Indications Iron deficiency anaemia; Peripheral arterial disorders
  • Focus Diagnostic use
  • Most Recent Events

    • 28 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top